GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IDEAYA Biosciences Inc (FRA:30J) » Definitions » Net Margin %

IDEAYA Biosciences (FRA:30J) Net Margin % : -1,861.60% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is IDEAYA Biosciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. IDEAYA Biosciences's Net Income for the three months ended in Dec. 2024 was €-124.45 Mil. IDEAYA Biosciences's Revenue for the three months ended in Dec. 2024 was €6.69 Mil. Therefore, IDEAYA Biosciences's net margin for the quarter that ended in Dec. 2024 was -1,861.60%.

The historical rank and industry rank for IDEAYA Biosciences's Net Margin % or its related term are showing as below:

FRA:30J' s Net Margin % Range Over the Past 10 Years
Min: -3942.31   Med: -178.1   Max: -115.17
Current: -3942.31


FRA:30J's Net Margin % is ranked worse than
86.65% of 1004 companies
in the Biotechnology industry
Industry Median: -134.985 vs FRA:30J: -3942.31

IDEAYA Biosciences Net Margin % Historical Data

The historical data trend for IDEAYA Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEAYA Biosciences Net Margin % Chart

IDEAYA Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial -176.56 -178.09 -115.16 -483.05 -3,921.11

IDEAYA Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -865.88 - - - -1,861.60

Competitive Comparison of IDEAYA Biosciences's Net Margin %

For the Biotechnology subindustry, IDEAYA Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEAYA Biosciences's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IDEAYA Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where IDEAYA Biosciences's Net Margin % falls into.



IDEAYA Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

IDEAYA Biosciences's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-262.126/6.685
=-3,921.11 %

IDEAYA Biosciences's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-124.448/6.685
=-1,861.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDEAYA Biosciences  (FRA:30J) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


IDEAYA Biosciences Net Margin % Related Terms

Thank you for viewing the detailed overview of IDEAYA Biosciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEAYA Biosciences Business Description

Traded in Other Exchanges
Address
5000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

IDEAYA Biosciences Headlines

No Headlines